Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Program to enhance heart health in patients getting stem cell transplants

Official title: Cardio-Oncology Prehabilitation Program to Improve Cardiac Reserve in High-Risk Patients Undergoing Hematopoietic Stem Cell Transplantation

Run by University of Michigan Rogel Cancer Center · NCT05945121 · Data updated 2026-11-12

This study tests a heart health program for patients with cardiovascular risks who are getting stem cell transplants to see if it helps them get fitter and avoid heart problems.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment10 (estimated)
SponsorUniversity of Michigan Rogel Cancer Center
Academic / other
Locations1 site (Ann Arbor, Michigan)
StatusRecruiting
StartedAugust 25, 2023
Main results expectedAugust 2027
Study endsAugust 2027
Registry record updatedMay 4, 2026
Trial IDNCT05945121 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 and older who are referred for hematopoietic stem cell transplantation and have at least one cardiovascular risk factor.

Probably not a fit

Patients with severe cardiovascular conditions or those unable to ambulate unassisted may not benefit from this program.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates a Cardio-Oncology Prehabilitation program aimed at improving cardiorespiratory fitness and reducing cardiovascular complications in high-risk patients undergoing hematopoietic stem cell transplantation. It focuses on patients with existing cardiovascular risk factors and assesses the feasibility and preliminary effectiveness of the intervention. Participants will engage in a structured program designed to enhance their cardiovascular health before the transplant procedure.

Why it matters

Potential benefit: If successful, this program could significantly improve heart health and reduce complications for patients undergoing stem cell transplants.

How similar studies have gone: Other studies have shown promising results with prehabilitation programs in similar patient populations, indicating potential for success in this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adult 18 years or older
* Referred for HSCT evaluation
* Presence of least one CV risk factor at enrollment (hypertension, hyperlipidemia, atrial fibrillation, obesity, heart failure, history of coronary artery disease, diabetes)
* Able to ambulate unassisted
* Ability to understand and the willingness to sign a written informed consent
* Ability to use Polar Flow heart rate application

Exclusion Criteria:

* Severe anemia (hemoglobin \<7 gm/dl)
* Untreated high-risk coronary artery disease (left main, triple vessel disease)
* Severe aortic stenosis
* Recent fracture as assessed via self-report
* Gross balance deficits
* Severe pain with basic movement
* Unable to ambulate unassisted or exercise
* NYHA class IV heart failure
* Adults unable to give consent, pregnant women, and prisoners are excluded from this study.

Where it's running

  • University of Michigan Rogel Cancer Center
    Ann Arbor, Michigan, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Early Cognitive Behavioral Therapy for Insomnia Before Stem Cell Transplant

    This trial tests whether starting six telehealth CBT-I sessions before hematopoietic stem cell transplant can help adults with insomnia feel better and have less fatigue.

    Recruiting Phase 1 University of Kansas Medical Center · Kansas City, Kansas · NCT07774039

  • Coping skills training for patients after stem cell transplant

    This study is testing a new coping skills program to see if it helps people who have had a stem cell transplant manage pain, fatigue, and stress better than usual care.

    Recruiting Duke University · Durham, North Carolina · NCT06575712

  • Preventing GvHD in patients with blood cancers undergoing stem cell transplants

    This study is testing a new treatment called TRX-103 to see if it can help prevent graft-versus-host disease in people with blood cancers who are getting stem cell transplants from mismatched donors.

    Recruiting at 5 sites Phase 1 Tr1X, Inc. · Duarte, California and 4 other locations · NCT06462365

  • Positive psychology support for survivors of stem cell transplants

    This study is testing a new program that helps people who have had stem cell transplants feel happier and less anxious by encouraging them to do enjoyable activities.

    Recruiting at 3 sites Brigham and Women's Hospital · Tampa, Florida and 2 other locations · NCT06328127

  • T Cell Therapy for Cytomegalovirus Infections

    This study is testing whether using special immune cells from donors can help patients who had a stem cell transplant fight off cytomegalovirus infections.

    Recruiting Early Phase 1 Case Comprehensive Cancer Center · Cleveland, Ohio · NCT02982902

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.